Name: Medical Isotope Production Market Size and Trends 2040
Creator: Roots Analysis
Published: 2026-08-13T00:00:01+05:30
License: https://www.rootsanalysis.com/privacy.html
Keywords: Medical Isotope Production Market, Medical Isotope Production Market Growth, Medical Isotope Production Market Trends, Medical Isotope Production Market Size, Medical Isotope Production Market Share, Medical Isotope Production Market Analysis, Medical Isotope Production Market Forecast, Medical Isotope Production Market Report, Global Medical Isotope Production Market, Medical Isotope Production Industry

Market Size

The global medical isotope production market, valued at USD 6.7 billion in 2025, is projected to reach USD 7.5 billion in 2026 and USD 18.0 billion by 2040, representing a CAGR of 6.4% during the forecast period 2026 to 2040.

Global Medical Isotope Production Market Growth 2025

See What’s in the Full Report – Request Your Complimentary Insights!

Market Report: Key Takeaways

The commercial scale sub-segment dominates (89%) the overall medical isotope production market.
Radioisotope sub-segment dominates the current medical isotope production market.
Technetium-99m is the most popular type of radioisotope in the overall market.
Nuclear reactors account for the highest share (75%) of the overall market, followed by accelerators and other methods.

Medical Isotope Production Market Share by Type of Production Method, 2026

Diagnosis is the most popular application area, capturing the largest share (64%) of the overall medical isotope production market.
With respect to the type of diagnostic radioisotopes, SPECT radioisotopes dominate the current market.
Gamma emitters currently hold the highest market share, among therapeutic radioisotopes.
Oncological disorders hold the largest share (40%), among therapeutic areas, of the overall market.
In terms of end-users, hospitals hold the highest share of the market.
North America captures nearly 45% of the overall market.

Methodology and Industry Experts Interviews

The findings presented in this study were developed through a structured research methodology combining extensive secondary research, proprietary databases, company disclosures, regulatory filings, academic and industry publications, and primary research. Inputs were triangulated across production capacity, isotope availability, supply-chain reliability, regulatory and quality requirements, clinical adoption, and regional market conditions to validate the market assumptions and forecast estimates. The report includes detailed transcripts of interviews conducted with the following industry participants:

David Harris (President and Chief Executive Officer of Christel House International), stated, “The global market for Isotopes is growing. The global demand for Lutetium is predicted to become a billion dollar market. That is sort of known and that is a huge supply amount for Lutetium. The FDA has almost 200 drugs undergoing clinical trials that are all based on Lutetium and are targeting different types of cancers.”

The analysis is further supported by relevant third-party expert discussions with multiple stakeholders influenced the opinions and insights presented in this study. The market report includes detailed transcripts of interviews conducted with the following individuals:

Managing Director, Small Organization, Netherlands
Chief Executive Officer, Mid-sized Organization, Canada

In addition, the market report includes transcripts of the following other third-party discussions:

Director, Business Development & Strategic Supply, Mid-sized Organization, Canada
Nuclear and Radiological Engineering and Medical Physics program Chair, Large Organization, US
Medical Radioisotopes Advisor, Very Large Organization, France
Senior Director, Nuclear Medicine, Small Organization, UK
Future Leaders Fellow, Large Organization, UK
Staff Radiologist and Nuclear Medicine Physician, Large Organization, Canada

Market Overview

Medical isotopes represent a critical component in modern targeted cancer therapies, enabling the delivery of highly potent agents in the form of radioisotope medicine. By integrating various technological advancements in production methods, medical isotope production companies are manufacturing high-quality radioisotopes to be utilized in the healthcare industry.

The radiopharmaceutical sector continues to expand rapidly by leveraging innovations in medical isotope chemistry, production methods, and purification technologies to refine safety and efficacy profiles. However, the field still encounters certain challenges including large-scale medical isotope production, cost intensive logistics, high capital investment needs, along with meeting stringent regulatory and quality standards for clinical deployment.

Achieving stability in supply chain and establishing new research reactor facilities remain significant hurdles for widespread adoption. However, expanding applications in cancer therapies and the rising global trend of personalized medicine are fueling market growth.

Recent Developments

SHINE Technologies and C-Ray Therapeutics: signed an agreement, in March 2026, for the distribution of Non-Carrier-Added Lutetium-177 in Mainland China.
Curium Pharma, PeptiDream and PDRadiopharma: entered into an agreement, in February 2026, to enroll first patient in the registrational clinical trial of Lutetium-177 PSMA therapy, for the treatment of prostate cancer, in Japan.
Bruce Power and Kinectrics: partnered, in January 2026, to manufacture a new hot-cell facility, to accelerate the large-scale production of medical radioisotopes in Ontario.

Your Business is Unique – Why Shouldn’t Your Report Be?

Medical Isotope Production Market Trends

Partnerships and Collaborations: The global medical isotope production market is witnessing a growing number of partnerships, expected to drive the growth in this market. For instance, market players, such as Eckert & Ziegler and Telix, are actively collaborating to expand production capabilities and streamline the clinical translation of radiopharmaceuticals, especially in oncology imaging and targeted radionuclide therapy. Several companies are entering technology licensing and joint R&D partnerships to develop non-reactor-based isotope production methods. This is particularly notable for molybdenum-99 and technetium-99m, where cyclotron and accelerator-based approaches are gaining traction to reduce dependence on aging reactors and address supply constraints. These efforts are expected to improve supply reliability, enhance regional self-sufficiency, and meet rising demand in nuclear medicine.
Funding and Investments: Over the years, monetary assistance from angel investors, venture capitalists, and funding schemes of various public and private organizations, along with assistance from regulatory authorities, have allowed start-ups / small companies to progress their R&D efforts in the medical isotope production industry. SpectronRx recently secured an investment worth $85 million from OrbiMed, aimed at scaling up manufacturing infrastructure and alleviating the supply constraints associated with critical therapeutic isotopes.

Market Drivers

Expansion of production facilities: Medical isotope production companies are expanding their production facilities rapidly, enabling them to ensure large scale production of multiple medical radioisotopes at a time. This expansion is supported by growing investments in advanced hot-cell technologies, nuclear reactor infrastructure, and accelerator- and cyclotron-based production facilities, which enhance production capacity, improve supply reliability, and help meet the increasing demand for diagnostic and therapeutic radioisotopes.
Growing interest in targeted and personalized radiotherapies: Advanced therapeutics such as Lutetium-177, Thorium-228, and Yttrium-90 are involved in targeted radionuclide therapies. Diagnostic isotopes such as fluorine-18 and technetium-99m are widely used in PET and SPECT imaging, respectively. Technetium-99m is commonly obtained from molybdenum-99/technetium-99m generator systems, making reliable Mo-99 production critical to the nuclear medicine supply chain.

Pay Only for What You Need – The Best Way to Optimize

Market Segmentation Analysis

Preclinical / Clinical Scale Driving Medical Isotope Production Market

Commercial scale accounts for the largest market share (89%) of the overall market. This is due to the evolving landscape of nuclear medicine and the radiopharmaceutical sector, which has witnessed increased commercialization of isotope-based therapies. The medical isotope production market for preclinical / clinical scale sub-segment is likely to grow at a relatively higher CAGR, showcasing substantial growth potential during the forecast period. This is due to expanding pipeline of isotope based radiopharmaceutical products, particularly targeted radionuclide therapies.

Radioisotopes Lead the Medical Isotope Production Market

Radioisotopes currently capture the majority share within the medical isotope production market. This can be primarily attributed to the fact that radioisotopes have emerged as a promising alternative in contemporary healthcare industry, addressing the limitations of traditional diagnostic and surgical methods, such as lower accuracy and invasiveness. The market for stable isotopes is expected to grow at a higher pace owing to their growing applications in the diagnostic application area. In March 2026, Theragenics entered into a collaboration with Clarity Pharmaceuticals in order to manufacture and supply stable isotopes for diagnostic purposes.

Nuclear Reactors Set to Lead Medical Isotope Production Industry

Nuclear reactors dominate the overall market, accounting for 75% share. This can be attributed to the established infrastructure and ability to support large-scale production of high-demand isotopes, including molybdenum-99, iodine-131 and lutetium-177. Additionally, nuclear reactors offer high neutron flux, enabling efficient production of isotopes that require neutron irradiation and are difficult to manufacture through alternative methods.

We anticipate accelerator sub-segment to grow at a relatively higher CAGR during the forecast period. This is due to increasing adoption of cyclotron and linear accelerator-based production methods for decentralized and patient-specific isotope supply. Additionally, accelerators enable the production of emerging therapeutic isotopes, including actinium-225, copper-67 and zirconium-89, which are gaining importance in targeted radiopharmaceutical therapies and PET imaging.

Diagnosis is the Most Prominent Application

Medical isotopes being used for diagnosis capture the majority (64%) of the share and are expected to remain dominant during the forecast period. This is because of the growing number of cancer cases, due to lifestyle changes and environmental factors, resulting in a heightened demand for early diagnosis using non-invasive solutions.

Oncological Disorders Lead the Medical Isotope Production Market

Oncological disorders capture the majority (40%) share within the medical isotope production market, as a result of the rising prevalence of oncological disorders across the globe. The utilization of radiopharmaceuticals for the diagnosis and treatment of such disorders is steadily increasing. The market for neurological disorders sub-segment will grow at a relatively high CAGR due to a rapid surge in the incidence of neurodegenerative disorders.

Global Medical Isotope Production Market Size by Therapeutic Area, 2026

Market Regional Insights

North America Dominates the Medical Isotope Production Market

North America holds the highest share (45%) of the overall market, owing to the higher acceptance of radiotherapies among patients in developed regions, particularly in the US. Nuclear technology advancements in this region, such as incorporation of computer-driven robotic technology for the production of medical isotopes, positions it for significant growth in the future.

Medical Isotope Production Adoption in the Asia-Pacific Region

Owing to the growing geriatric population and rise in the number of cancer and cardiovascular disease cases, along with the technological advancements in medical imaging technologies, the market for medical isotopes in Asia-Pacific is likely to grow at a higher rate during the forecast period.

Get an Instant Quote in 10 Minutes. Lowest Price Guaranteed

Key Players in the Medical Isotope Production Market

Examples of key companies profiled in this market report include Cardinal Health, Curium Pharma, Eden Radioisotopes, NorthStar Medical Radioisotopes, Nusano, SpectronRx, ABX advanced biochemical compounds, CMR Isotopes, Eckert & Ziegler, ROTOP Pharmaka, China Isotope & Radiation Corporation, and Global Medical Solutions. The complete list of close to 65 companies is available in the full report, which also includes an easily searchable Excel database of companies worldwide. Additional named organizations referenced elsewhere in this report's underlying data, including Bruce Power, Curium Pharma, C-Ray Therapeutics, Kinectric, PeptiDream, PDRadiopharma, and Shine Technologies, reflect initiatives undertaken across the medical isotope production ecosystem, not an endorsement relationship with Roots Analysis.

Market Segments

Based on the research, we have segmented the Medical Isotope Production Market into Scale of Operation, Type of Isotope, Radioisotope, Production Method, Application Area, Type of Diagnostic Radioisotope, Type of Therapeutic Radioisotope, Therapeutic Area, End-Users, and Geographical Regions.

By Scale of Operation

Commercial Scale, Preclinical / Clinical Scale

By Type of Isotope

Radioisotopes, Stable Isotopes

By Type of Radioisotope

Technetium-99m, Lutetium-177, Fluorine-18, Other Radioisotopes

By Type of Production Method

Nuclear Reactors, Accelerators, Other Methods

By Application Area

Diagnosis, Nuclear Therapy, Other Applications

By Type of Diagnostic Radioisotope

SPECT Radioisotopes, PET Radioisotopes

By Type of Therapeutic Radioisotope

Gamma Emitters, Beta Emitters, Other Emitters

By Therapeutic Area

Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Other Areas

By End-Users

Hospitals, Diagnostic Centers, Research Institutes

By Geographical Regions

North America, Europe, Asia-Pacific, Middle East and Africa, Latin America

Report Deliverables and Customization

Alongside the core market report, clients receive complimentary Excel data packs covering the medical isotope production market landscape, company competitiveness analysis, partnerships and collaborations, funding and investments, vendor selection framework, and market sizing and opportunity analysis. A complimentary PowerPoint presentation summarizing the full report is also included, and 15% free customization scope is available on request.

Report Authorship

Author(s): This report was co-authored by Rupali Bhardawaj and Rashmeet Kaur, both part of Roots Analysis’s healthcare and pharma research practice, with a focus on the medical isotope production market, including isotope generation, processing, and supply for diagnostic imaging, therapeutic applications, and research. All findings are based on proprietary databases, executive interviews, and regulatory analysis, and were subject to internal peer review prior to publication.

Independence and Non-Affiliation

Roots Analysis is an independent market research and consulting firm. This report draws on publicly available information, primary interviews, and proprietary analysis. Roots Analysis is not affiliated with, endorsed by, or a representative of the USFDA, the European Medicines Agency, or any of the pharmaceutical companies, branded therapeutics, or individuals named in this report. All company and product names are used for identification purposes only and remain the property of their respective owners.

Roots Analysis maintains its own proprietary primary research process, and does not receive compensation from any company profiled within the report, in exchange for inclusion or favorable characterization.

Clients evaluating this report alongside competing market studies should weigh two factors in particular: whether the segmentation depth matches their specific decision, and whether the publisher discloses its own independence from the companies and regulatory bodies it covers.

+ 1. BACKGROUND

1.1. Context

1.2. Project Objectives

+ 2. RESEARCH METHODOLOGY

2.1. Chapter Overview

2.2. Research Assumptions

2.2.1. Market Landscape and Market Trends

2.2.2. Market Forecast and Opportunity Analysis

2.2.3. Comparative Analysis

2.3. Database Building

2.3.1. Data Collection

2.3.2. Data Validation

2.3.3. Data Analysis

2.4. Project Methodology

2.4.1. Secondary Research

2.4.1.1. Annual Reports

2.4.1.2. Academic Research Papers

2.4.1.3. Company Websites

2.4.1.4. Investor Presentations

2.4.1.5. Regulatory Filings

2.4.1.6. White Papers

2.4.1.7. Industry Publications

2.4.1.8. Conferences and Seminars

2.4.1.9. Government Portals

2.4.1.10. Media and Press Releases

2.4.1.11. Newsletters

2.4.1.12. Industry Databases

2.4.1.13. Roots Proprietary Databases

2.4.1.14. Paid Databases and Sources

2.4.1.15. Social media portals

2.4.1.16. Other Secondary Sources

2.4.2. Primary Research

2.4.2.1. Types of Primary Research

2.4.2.1.1. Qualitative Research

2.4.2.1.2. Quantitative Research

2.4.2.1.3. Hybrid Approach

2.4.2.2. Advantages of Primary Research

2.4.2.3. Techniques for Primary Research

2.4.2.3.1. Interviews

2.4.2.3.2. Surveys

2.4.2.3.3. Focus Groups

2.4.2.3.4. Observational Research

2.4.2.3.5. Social Media Interactions

2.4.2.4. Key Opinion Leaders Considered in Primary Research

2.4.2.4.1. Company Executives (CXOs)

2.4.2.4.2. Board of Directors

2.4.2.4.3. Company Presidents and Vice Presidents

2.4.2.4.4. Research and Development Heads

2.4.2.4.5. Technical Experts

2.4.2.4.6. Subject Matter Experts

2.4.2.4.7. Scientists

2.4.2.4.8. Doctors and Other Healthcare Providers

2.4.2.5. Ethics and Integrity

2.4.2.5.1. Research Ethics

2.4.2.5.2. Data Integrity

2.4.3. Analytical Tools and Databases

2.5. Robust Quality Control

+ 3. MARKET DYNAMICS

3.1. Chapter Overview

3.2. Forecast Methodology

3.2.1. Top-down Approach

3.2.2. Bottom-up Approach

3.2.3. Hybrid Approach

3.3. Market Assessment Framework

3.3.1. Total Addressable Market (TAM)

3.3.2. Serviceable Addressable Market (SAM)

3.3.3. Serviceable Obtainable Market (SOM)

3.3.4. Currently Acquired Market (CAM)

3.4. Forecasting Tools and Techniques

3.4.1. Qualitative Forecasting

3.4.2. Correlation

3.4.3. Regression

3.4.4. Extrapolation

3.4.5. Convergence

3.4.6. Sensitivity Analysis

3.4.7. Scenario Planning

3.4.8. Data Visualization

3.4.9. Time Series Analysis

3.4.10. Forecast Error Analysis

3.5. Key Considerations

3.5.1. Demographics

3.5.2. Government Regulations

3.5.3. Reimbursement Scenarios

3.5.4. Market Access

3.5.5. Supply Chain

3.5.6. Industry Consolidation

3.5.7. Pandemic / Unforeseen Disruptions Impact

3.6. Limitations

+ 4. MACRO-ECONOMIC INDICATORS

4.1. Chapter Overview

4.2. Market Dynamics

4.2.1. Time Period

4.2.1.1. Historical Trends

4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage

4.2.2.1. Major Currencies Affecting the Market

4.2.2.2. Factors Affecting Currency Fluctuations in the Industry

4.2.2.3. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Currency Exchange Rate

4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market

4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession

4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt

4.2.5. Inflation

4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy

4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates

4.2.6.1. Interest Rates and Their Impact on the Market

4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis

4.2.7.1. Type of Commodity

4.2.7.2. Origins and Destinations

4.2.7.3. Values and Weights

4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics

4.2.8.1. Import Scenario

4.2.8.2. Export Scenario

4.2.8.3. Trade Policies

4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers

4.2.8.5. Impact of Trade Barriers on the Market

4.2.9. War Impact Analysis

4.2.9.1. Russian-Ukraine War

4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors

4.2.10.1. Global Economic Impact

4.2.10.2. Industry-specific Impact

4.2.10.3. Government Response and Stimulus Measures

4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators

4.2.11.1. Fiscal Policy

4.2.11.2. Consumer Spending

4.2.11.3. Gross Domestic Product

4.2.11.4. Employment

4.2.11.5. Taxes

4.2.11.6. Stock Market Performance

4.2.11.7. Cross Border Dynamics

4.3. Conclusion

+ 5. EXECUTIVE SUMMARY

5.1. Medical Isotope Production: Market Landscape

5.2. Medical Isotope Production: Market Trends

5.3. Medical Isotope Production: Market Forecast and Opportunity Analysis

+ 6. INTRODUCTION

6.1. Overview of Isotopes

6.2. Types of Isotopes

6.3. Properties of Isotopes

6.4. Isotope Production Methods

6.5. Application of Isotopes

6.5.1. Role of Isotopes in Oncology

6.6. Challenges Associated with Isotopes

6.7. Recent Developments and Future Perspectives

+ 7. MARKET LANDSCAPE

7.1. Methodology and Key Parameters

7.2. Medical Isotope Manufacturers: Market Landscape

7.2.1. Analysis by Year of Establishment

7.2.2. Analysis by Company Size

7.2.3. Analysis by Location of Headquarters

7.2.4. Analysis by Source of Isotope

7.2.5. Analysis by Type of Isotope

7.2.6. Analysis by Type of Production Method

7.2.7. Analysis by Application Area

7.2.8. Analysis by End-User

+ 8. COMPANY COMPETITIVENESS ANALYSIS

8.1. Methodology and Key Parameters

8.2. Scoring Criteria

8.3. Peer Groups

8.4. Company Competitiveness Analysis: Medical Isotope Manufacturers

8.4.1. North America (Peer group I): Overview

8.4.1.1. Medical Isotope Manufacturers in North America: Peer Group I

8.4.2. Europe (Peer group II): Overview

8.4.2.1. Medical Isotope Manufacturers in Europe: Peer Group II

8.4.3. Asia-Pacific & RoW (Peer group III): Overview

8.4.3.1. Medical Isotope Manufacturers in Asia-Pacific and Rest of the World: Peer Group III

8.5. Medical Isotope Manufacturers: Benchmarking Analysis

8.5.1. Benchmarking based on Company Strength Score

8.5.2. Benchmarking based on Portfolio Strength Score

8.5.3. Benchmarking based on Portfolio Diversity Score

+ 9. COMPANY PROFILES: MEDICAL ISOTOPE MANUFACTURERS BASED IN NORTH AMERICA

9.1. Overview

9.2. Cardinal Health

9.2.1. Company Details

9.2.2. Manufacturing Portfolio

9.2.3. Recent Developments

9.3. Curium Pharma

9.3.1. Company Details

9.3.2. Manufacturing Portfolio

9.3.3. Recent Developments

9.4. Eden Radioisotopes

9.4.1. Company Details

9.4.2. Manufacturing Portfolio

9.5. NorthStar Medical Radioisotopes

9.5.1. Company Details

9.5.2. Manufacturing Portfolio

9.5.3. Recent Developments

9.6. Nusano

9.6.1. Company Details

9.6.2. Manufacturing Portfolio

9.6.3. Recent Developments

9.7. SpectronRx

9.7.1. Company Details

9.7.2. Manufacturing Portfolio

9.7.3. Recent Developments

+ 10. COMPANY PROFILES: MEDICAL ISOTOPE MANUFACTURERS BASED IN EUROPE

10.1. ABX advanced biochemical compounds

10.1.1. Company Details

10.1.2. Manufacturing Portfolio

10.1.3. Recent Developments

10.2. CMR Isotopes

10.2.1. Company Details

10.2.2. Manufacturing Portfolio

10.2.3. Recent Developments

10.3. Eckert & Ziegler

10.3.1. Company Details

10.3.2. Manufacturing Portfolio

10.3.3. Recent Developments

10.4. ROTOP Pharmaka

10.4.1. Company Details

10.4.2. Manufacturing Portfolio

10.4.3. Recent Developments

+ 11. COMPANY PROFILES: MEDICAL ISOTOPE MANUFACTURERS BASED IN ASIA-PACIFIC AND REST OF THE WORLD

11.1. China Isotope & Radiation Corporation

11.1.1. Company Details

11.1.2. Manufacturing Portfolio

11.1.3. Recent Developments

11.2. Global Medical Solutions

11.2.1. Company Details

11.2.2. Manufacturing Portfolio

+ 12. PARTNERSHIPS AND COLLABORATIONS

12.1. Partnership Models

12.2. Medical Isotope Manufacturers: Partnerships and Collaborations

12.2.1. Analysis by Year of Partnership

12.2.2. Analysis by Type of Partnership

12.2.3. Analysis by Year and Type of Partnership

12.2.4. Analysis by Isotope Offered

12.2.5. Analysis by Application Area

12.2.6. Most Active Players: Analysis by Number of Partnerships

12.2.7. Analysis by Geography

12.2.7.1. Local and International Deals

12.2.7.2. Intracontinental and Intercontinental Deals

+ 13. FUNDING AND INVESTMENTS ANALYSIS

13.1. Funding Models

13.2. Funding Lifecycle Analysis

13.3. Investment Case: Risk and Return

13.4. Medical Isotope Manufacturers: Funding and Investments Analysis

13.4.1. Analysis of Instances by Year of Funding

13.4.2. Analysis of Instances by Type of Funding

13.4.3. Analysis of Instances by Year and Type of Funding

13.4.4. Analysis of Amount by Year of Funding

13.4.5. Analysis of Amount by Type of Funding

13.4.6. Analysis of Amount by Year and Type of Funding

13.4.7. Analysis by Geography

13.4.8. Most Active Players: Analysis by Number of Instances

13.4.9. Most Active Players: Analysis by Amount Raised

13.4.10. Most Active Investors: Analysis by Number of Instances

13.5. Evolution and Relative Assessment of Funding Models

13.5.1. Grants / Awards

13.5.2. Private Placement

13.5.3. Venture Capital

13.6. Summary

13.7. Investment Opportunities

+ 14. MARKET IMPACT ANALYSIS

14.1. Market Drivers

14.2. Market Restraints

14.3. Market Opportunities

14.4. Market Challenges

+ 15. GLOBAL MEDICAL ISOTOPE PRODUCTION MARKET

15.1. Key Assumptions and Methodology

15.2. Global Medical Isotope Production Market, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

15.2.1. Scenario Analysis

15.2.1.1. Conservative Scenario

15.2.1.2. Optimistic Scenario

15.3. Key Market Segmentations

15.4. Key Assumptions and Data Validation

+ 16. ISOTOPE PRODUCTION MARKET, BY SCALE OF OPERATION

16.1. Methodology

16.2. Medical Isotope Production Market, by Scale of Operation

16.2.1. Medical Isotope Production Market for Preclinical / Clinical Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

16.2.2. Medical Isotope Production Market for Commercial Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

16.3. Data Triangulation and Validation

+ 17. MEDICAL ISOTOPE PRODUCTION MARKET, BY TYPE OF ISOTOPE

17.1. Methodology

17.2. Medical Isotope Production Market, by Type of Isotope

17.2.1. Medical Isotope Production Market for Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

17.2.2. Medical Isotope Production Market for Stable Isotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

17.3. Data Triangulation and Validation

+ 18. MEDICAL ISOTOPE PRODUCTION MARKET, BY TYPE OF RADIOISOTOPE

18.1. Methodology

18.2. Medical Isotope Production Market, by Type of Radioisotope

18.2.1. Medical Isotope Production Market for Technetium-99m, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

18.2.2. Medical Isotope Production Market for Lutetium-177, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

18.2.3. Medical Isotope Production Market for Fluorine-18, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

18.2.4. Medical Isotope Production Market for Other Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

18.3. Data Triangulation and Validation

+ 19. MEDICAL ISOTOPE PRODUCTION MARKET, BY TYPE OF PRODUCTION METHOD

19.1. Methodology

19.2. Medical Isotope Production Market, by Type of Production Method

19.2.1. Medical Isotope Production Market for Nuclear Reactors, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

19.2.2. Medical Isotope Production Market for Accelerators, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

19.2.3. Medical Isotope Production Market for Other Methods, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

19.3. Data Triangulation and Validation

+ 20. MEDICAL ISOTOPE PRODUCTION MARKET, BY APPLICATION AREA

20.1. Methodology

20.2. Medical Isotope Production Market, by Application Area

20.2.1. Medical Isotope Production Market for Diagnosis, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

20.2.2. Medical Isotope Production Market for Nuclear Therapy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

20.2.3. Medical Isotope Production Market for Other Applications, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

20.3. Data Triangulation and Validation

+ 21. MEDICAL ISOTOPE PRODUCTION MARKET, BY TYPE OF DIAGNOSTIC RADIOISOTOPE

21.1. Methodology

21.2. Medical Isotope Production Market, by Type of Diagnostic Radioisotope

21.2.1. Medical Isotope Production Market for SPECT Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

21.2.2. Medical Isotope Production Market for PET Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

21.3. Data Triangulation and Validation

+ 22. MEDICAL ISOTOPE PRODUCTION MARKET, BY TYPE OF THERAPEUTIC RADIOISOTOPE

22.1. Methodology

22.2. Medical Isotope Production Market, by Type of Therapeutic Radioisotope

22.2.1. Medical Isotope Production Market for Gamma Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

22.2.2. Medical Isotope Production Market for Beta Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

22.2.3. Medical Isotope Production Market for Other Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

22.3. Data Triangulation and Validation

+ 23. MEDICAL ISOTOPE PRODUCTION MARKET, BY THERAPEUTIC AREA

23.1. Methodology

23.2. Medical Isotope Production Market, by Therapeutic Area

23.2.1. Medical Isotope Production Market for Oncological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

23.2.2. Medical Isotope Production Market for Cardiovascular Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

23.2.3. Medical Isotope Production Market for Neurological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

23.2.4. Medical Isotope Production Market for Other Areas, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

23.3. Data Triangulation and Validation

+ 24. MEDICAL ISOTOPE PRODUCTION MARKET, BY END-USERS

24.1. Methodology

24.2. Medical Isotope Production Market, by End-Users

24.2.1. Medical Isotope Production Market for Hospitals, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

24.2.2. Medical Isotope Production Market for Diagnostic Centers, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

24.2.3. Medical Isotope Production Market for Research Institutes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

24.3. Data Triangulation and Validation

+ 25. MEDICAL ISOTOPE PRODUCTION MARKET, BY GEOGRAPHICAL REGIONS

25.1. Methodology

25.2. Medical Isotope Production Market: Distribution by Geographical Regions

25.2.1. Medical Isotope Production Market in North America, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.1.1. Medical Isotope Production Market in the US, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.1.2. Medical Isotope Production Market in Canada, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.2. Medical Isotope Production Market in Europe, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.2.1. Medical Isotope Production Market in Germany, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.2.2. Medical Isotope Production Market in the UK, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.2.3. Medical Isotope Production Market in France, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.2.4. Medical Isotope Production Market in Italy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.2.5. Medical Isotope Production Market in Spain, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.2.6. Medical Isotope Production Market in Rest of Europe, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.3. Medical Isotope Production Market in Asia-Pacific, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.3.1. Medical Isotope Production Market in China, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.3.2. Medical Isotope Production Market in Japan, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.3.3. Medical Isotope Production Market in Australia, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.3.4. Medical Isotope Production Market in South Korea, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.3.5. Medical Isotope Production Market in India, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) 25.2.3.6. Medical Isotope Production Market in Rest of Asia-Pacific, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.4. Medical Isotope Production Market in the Middle East and Africa, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.4.1. Medical Isotope Production Market in Saudi Arabia, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.4.2. Medical Isotope Production Market in UAE, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.4.3. Medical Isotope Production Market in Egypt, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.5. Medical Isotope Production Market in Latin America, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.5.1. Medical Isotope Production Market in Brazil, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.2.5.2. Medical Isotope Production Market in Mexico, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) 25.2.5.3. Medical Isotope Production Market in Argentina, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

25.3. Medical Isotope Production Market, by Geographical Regions: Market Dynamics Assessment

25.3.1. Market Movement Analysis

25.3.2. Penetration Growth (P-G) Matrix

25.4. Data Triangulation and Validation

+ 26. MARKET OPPORTUNITY ANALYSIS: NORTH AMERICA

26.1. Medical Isotope Production Market in North America: Distribution by Scale of Operation

26.1.1. Medical Isotope Production Market in North America for Preclinical / Clinical Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.1.2. Medical Isotope Production Market in North America for Commercial Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.2. Medical Isotope Production Market in North America: Distribution by Type of Isotope

26.2.1. Medical Isotope Production Market in North America for Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.2.2. Medical Isotope Production Market in North America for Stable Isotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.3. Medical Isotope Production Market in North America: Distribution by Type of Radioisotope

26.3.1. Medical Isotope Production Market in North America for Technetium-99m, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.3.2. Medical Isotope Production Market in North America for Lutetium-177, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.3.3. Medical Isotope Production Market in North America for Fluorine-18, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.3.4. Medical Isotope Production Market in North America for Other Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.4. Medical Isotope Production Market in North America : Distribution by Type of Production Method

26.4.1. Medical Isotope Production Market in North America for Nuclear Reactors, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.4.2. Medical Isotope Production Market in North America for Accelerators, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.4.3. Medical Isotope Production Market in North America for Other Methods, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.5. Medical Isotope Production Market in North America: Distribution by Application Area

26.5.1. Medical Isotope Production Market in North America for Diagnosis, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.5.2. Medical Isotope Production Market in North America for Nuclear Therapy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.5.3. Medical Isotope Production Market in North America for Other Applications, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.6. Medical Isotope Production Market in North America: Distribution by Type of Diagnostic Radioisotope

26.6.1. Medical Isotope Production Market in North America for SPECT Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.6.2. Medical Isotope Production Market in North America for PET Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.7. Medical Isotope Production Market in North America: Distribution by Type of Therapeutic Radioisotope

26.7.1. Medical Isotope Production Market in North America for Gamma Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.7.2. Medical Isotope Production Market in North America for Beta Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.7.3. Medical Isotope Production Market in North America for Other Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.8. Medical Isotope Production Market in North America: Distribution by Therapeutic Area

26.8.1. Medical Isotope Production Market in North America for Oncological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.8.2. Medical Isotope Production Market in North America for Cardiovascular Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.8.3. Medical Isotope Production Market in North America for Neurological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.8.4. Medical Isotope Production Market in North America for Other Areas, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.9. Medical Isotope Production Market in North America: Distribution by End-Users

26.9.1. Medical Isotope Production Market in North America for Hospitals, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.9.2. Medical Isotope Production Market in North America for Diagnostic Centers, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

26.9.3. Medical Isotope Production Market in North America for Research Institutes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

+ 27. MARKET OPPORTUNITY ANALYSIS: EUROPE

27.1. Medical Isotope Production Market in Europe: Distribution by Scale of Operation

27.1.1. Medical Isotope Production Market in Europe for Preclinical / Clinical Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.1.2. Medical Isotope Production Market in Europe for Commercial Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.2. Medical Isotope Production Market in Europe: Distribution by Type of Isotope

27.2.1. Medical Isotope Production Market in Europe for Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.2.2. Medical Isotope Production Market in Europe for Stable Isotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.3. Medical Isotope Production Market in Europe: Distribution by Type of Radioisotope

27.3.1. Medical Isotope Production Market in Europe for Technetium-99m, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.3.2. Medical Isotope Production Market in Europe for Lutetium-177, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.3.3. Medical Isotope Production Market in Europe for Fluorine-18, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.3.4. Medical Isotope Production Market in Europe for Other Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.4. Medical Isotope Production Market in Europe: Distribution by Type of Production Method

27.4.1. Medical Isotope Production Market in Europe for Nuclear Reactors, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.4.2. Medical Isotope Production Market in Europe for Accelerators, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.4.3. Medical Isotope Production Market in Europe for Other Methods, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.5. Medical Isotope Production Market in Europe: Distribution by Application Area

27.5.1. Medical Isotope Production Market in Europe for Diagnosis, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.5.2. Medical Isotope Production Market in Europe for Nuclear Therapy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.5.3. Medical Isotope Production Market in Europe for Other Applications, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.6. Medical Isotope Production Market in Europe: Distribution by Type of Diagnostic Radioisotope

27.6.1. Medical Isotope Production Market in Europe for SPECT Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.6.2. Medical Isotope Production Market in Europe for PET Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.7. Medical Isotope Production Market in Europe: Distribution by Type of Therapeutic Radioisotope

27.7.1. Medical Isotope Production Market in Europe for Gamma Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.7.2. Medical Isotope Production Market in Europe for Beta Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.7.3. Medical Isotope Production Market in Europe for Other Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.8. Medical Isotope Production Market in Europe: Distribution by Therapeutic Area

27.8.1. Medical Isotope Production Market in Europe for Oncological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.8.2. Medical Isotope Production Market in Europe for Cardiovascular Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.8.3. Medical Isotope Production Market in Europe for Neurological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.8.4. Medical Isotope Production Market in Europe for Other Areas, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.9. Medical Isotope Production Market in Europe: Distribution by End-Users

27.9.1. Medical Isotope Production Market in Europe for Hospitals, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.9.2. Medical Isotope Production Market in Europe for Diagnostic Centers, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

27.9.3. Medical Isotope Production Market in Europe for Research Institutes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

+ 28. MARKET OPPORTUNITY ANALYSIS: ASIA-PACIFIC

28.1. Medical Isotope Production Market in Asia-Pacific: Distribution by Scale of Operation

28.1.1. Medical Isotope Production Market in Asia-Pacific for Preclinical / Clinical Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.1.2. Medical Isotope Production Market in Asia-Pacific for Commercial Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.2. Medical Isotope Production Market in Asia-Pacific: Distribution by Type of Isotope

28.2.1. Medical Isotope Production Market in Asia-Pacific for Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.2.2. Medical Isotope Production Market in Asia-Pacific for Stable Isotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.3. Medical Isotope Production Market in Asia-Pacific: Distribution by Type of Radioisotope

28.3.1. Medical Isotope Production Market in Asia-Pacific for Technetium-99m, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.3.2. Medical Isotope Production Market in Asia-Pacific for Lutetium-177, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.3.3. Medical Isotope Production Market in Asia-Pacific for Fluorine-18, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.3.4. Medical Isotope Production Market in Asia-Pacific for Other Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.4. Medical Isotope Production Market in Asia-Pacific: Distribution by Type of Production Method

28.4.1. Medical Isotope Production Market in Asia-Pacific for Nuclear Reactors, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.4.2. Medical Isotope Production Market in Asia-Pacific for Accelerators, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.4.3. Medical Isotope Production Market in Asia-Pacific for Other Methods, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.5. Medical Isotope Production Market in Asia-Pacific: Distribution by Application Area

28.5.1. Medical Isotope Production Market in Asia-Pacific for Diagnosis, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.5.2. Medical Isotope Production Market in Asia-Pacific for Nuclear Therapy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.5.3. Medical Isotope Production Market in Asia-Pacific for Other Applications, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.6. Medical Isotope Production Market in Asia-Pacific: Distribution by Type of Diagnostic Radioisotope

28.6.1. Medical Isotope Production Market in Asia-Pacific for SPECT Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.6.2. Medical Isotope Production Market in Asia-Pacific for PET Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.7. Medical Isotope Production Market in Asia-Pacific: Distribution by Type of Therapeutic Radioisotope

28.7.1. Medical Isotope Production Market in Asia-Pacific for Gamma Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.7.2. Medical Isotope Production Market in Asia-Pacific for Beta Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.7.3. Medical Isotope Production Market in Asia-Pacific for Other Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.8. Medical Isotope Production Market in Asia-Pacific: Distribution by Therapeutic Area

28.8.1. Medical Isotope Production Market in Asia-Pacific for Oncological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.8.2. Medical Isotope Production Market in Asia-Pacific for Cardiovascular Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.8.3. Medical Isotope Production Market in Asia-Pacific for Neurological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.8.4. Medical Isotope Production Market in Asia-Pacific for Other Areas, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.9. Medical Isotope Production Market in Asia-Pacific: Distribution by End-Users

28.9.1. Medical Isotope Production Market in Asia-Pacific for Hospitals, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.9.2. Medical Isotope Production Market in Asia-Pacific for Diagnostic Centers, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

28.9.3. Medical Isotope Production Market in Asia-Pacific for Research Institutes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

+ 29. MARKET OPPORTUNITY ANALYSIS: MIDDLE EAST AND AFRICA

29.1. Medical Isotope Production Market in the Middle East and Africa: Distribution by Scale of Operation

29.1.1. Medical Isotope Production Market in the Middle East and Africa for Preclinical / Clinical Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.1.2. Medical Isotope Production Market in the Middle East and Africa for Commercial Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.2. Medical Isotope Production Market in the Middle East and Africa: Distribution by Type of Isotope

29.2.1. Medical Isotope Production Market in the Middle East and Africa for Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.2.2. Medical Isotope Production Market in the Middle East and Africa for Stable Isotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.3. Medical Isotope Production Market in the Middle East and Africa: Distribution by Type of Radioisotope

29.3.1. Medical Isotope Production Market in the Middle East and Africa for Technetium-99m, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.3.2. Medical Isotope Production Market in the Middle East and Africa for Lutetium-177, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.3.3. Medical Isotope Production Market in the Middle East and Africa for Fluorine-18, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.3.4. Medical Isotope Production Market in the Middle East and Africa for Other Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.4. Medical Isotope Production Market in Middle East and Africa: Distribution by Type of Production Method

29.4.1. Medical Isotope Production Market in the Middle East and Africa for Nuclear Reactors, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.4.2. Medical Isotope Production Market in the Middle East and Africa for Accelerators, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.4.3. Medical Isotope Production Market in the Middle East and Africa for Other Methods, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.5. Medical Isotope Production Market in the Middle East and Africa: Distribution by Application Area

29.5.1. Medical Isotope Production Market in the Middle East and Africa for Diagnosis, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.5.2. Medical Isotope Production Market in the Middle East and Africa for Nuclear Therapy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.5.3. Medical Isotope Production Market in the Middle East and Africa for Other Applications, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.6. Medical Isotope Production Market in the Middle East and Africa: Distribution by Type of Diagnostic Radioisotope

29.6.1. Medical Isotope Production Market in the Middle East and Africa for SPECT Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.6.2. Medical Isotope Production Market in the Middle East and Africa for PET Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.7. Medical Isotope Production Market in the Middle East and Africa: Distribution by Type of Therapeutic Radioisotope

29.7.1. Medical Isotope Production Market in the Middle East and Africa for Gamma Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.7.2. Medical Isotope Production Market in the Middle East and Africa for Beta Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.7.3. Medical Isotope Production Market in the Middle East and Africa for Other Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.8. Medical Isotope Production Market in the Middle East and Africa: Distribution by Therapeutic Area

29.8.1. Medical Isotope Production Market in the Middle East and Africa for Oncological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.8.2. Medical Isotope Production Market in the Middle East and Africa for Cardiovascular Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.8.3. Medical Isotope Production Market in the Middle East and Africa for Neurological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.8.4. Medical Isotope Production Market in the Middle East and Africa for Other Areas, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.9. Medical Isotope Production Market in the Middle East and Africa: Distribution by End-Users

29.9.1. Medical Isotope Production Market in the Middle East and Africa for Hospitals, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.9.2. Medical Isotope Production Market in the Middle East and Africa for Diagnostic Centers, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

29.9.3. Medical Isotope Production Market in the Middle East and Africa for Research Institutes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

+ 30. MARKET OPPORTUNITY ANALYSIS: LATIN AMERICA

30.1. Medical Isotope Production Market in Latin America: Distribution by Scale of Operation

30.1.1. Medical Isotope Production Market in Latin America for Preclinical / Clinical Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.1.2. Medical Isotope Production Market in Latin America for Commercial Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.2. Medical Isotope Production Market in Latin America: Distribution by Type of Isotope

30.2.1. Medical Isotope Production Market in Latin America for Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.2.2. Medical Isotope Production Market in Latin America for Stable Isotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.3. Medical Isotope Production Market in Latin America: Distribution by Type of Radioisotope

30.3.1. Medical Isotope Production Market in Latin America for Technetium-99m, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.3.2. Medical Isotope Production Market in Latin America for Lutetium-177, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.3.3. Medical Isotope Production Market in Latin America for Fluorine-18, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.3.4. Medical Isotope Production Market in Latin America for Other Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.4. Medical Isotope Production Market in Latin America: Distribution by Type of Production Method

30.4.1. Medical Isotope Production Market in Latin America for Nuclear Reactors, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.4.2. Medical Isotope Production Market in Latin America for Accelerators, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.4.3. Medical Isotope Production Market in Latin America for Other Methods, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.5. Medical Isotope Production Market in Latin America: Distribution by Application Area

30.5.1. Medical Isotope Production Market in Latin America for Diagnosis, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.5.2. Medical Isotope Production Market in Latin America for Nuclear Therapy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.5.3. Medical Isotope Production Market in Latin America for Other Applications, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.6. Medical Isotope Production Market in Latin America: Distribution by Type of Diagnostic Radioisotope

30.6.1. Medical Isotope Production Market in Latin America for SPECT Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.6.2. Medical Isotope Production Market in Latin America for PET Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.7. Medical Isotope Production Market in Latin America: Distribution by Type of Therapeutic Radioisotope

30.7.1. Medical Isotope Production Market in Latin America for Gamma Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.7.2. Medical Isotope Production Market in Latin America for Beta Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.7.3. Medical Isotope Production Market in Latin America for Other Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.8. Medical Isotope Production Market in Latin America: Distribution by Therapeutic Area

30.8.1. Medical Isotope Production Market in Latin America for Oncological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.8.2. Medical Isotope Production Market in Latin America for Cardiovascular Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.8.3. Medical Isotope Production Market in Latin America for Neurological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.8.4. Medical Isotope Production Market in Latin America for Other Areas, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.9. Medical Isotope Production Market in Latin America: Distribution by End-Users

30.9.1. Medical Isotope Production Market in Latin America for Hospitals, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.9.2. Medical Isotope Production Market in Latin America for Diagnostic Centers, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

30.9.3. Medical Isotope Production Market in Latin America for Research Institutes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040)

**Detailed information on Section VII is available in the Excel Data Packs shared along with the report**

+ 31. VENDOR SELECTION FRAMEWORK ANALYSIS

31.1. Reasons to Outsource in Isotope Manufacturing

31.2. Commonly Outsourced Operations in Isotope Manufacturing

31.3. Key Parameters

31.4. Methodology for Vendor Selection Framework

31.5. Benchmarking of Parameters

31.6. Value Addition vs Evaluation Complexity Matrix

31.7. Case Study Assessment of NorthStar Medical Radioisotopes

31.8. Overview of Vendor Assessment Dashboard

31.8.1. Scenario I

31.8.2. Scenario II

31.8.3. Scenario III

+ 32. CONCLUDING INSIGHTS

+ 33. EXECUTIVE INSIGHTS

+ 34. TABULATED DATA

+ 35. LIST OF COMPANIES AND ORGANIZATIONS

+ List of Figures

Figure 2.1 Research Methodology: Project Methodology

Figure 2.2 Research Methodology: Data Sources for Secondary Research

Figure 2.3 Research Methodology: Robust Quality Control

Figure 3.1 Market Dynamics: Forecast Methodology

Figure 3.2 Market Dynamics: Market Assessment Framework

Figure 3.3 Market Dynamics: Example List of Parameters

Figure 4.1 Lessons Learnt from Past Recessions

Figure 5.1 Executive Summary: Market Landscape

Figure 5.2 Executive Summary: Market Trends

Figure 5.3 Executive Summary: Market Sizing and Opportunity Analysis

Figure 6.1 Types of Isotopes Properties of Isotopes

Figure 6.2 Properties of Isotopes Isotope Production Methods

Figure 6.3 Isotope Production Methods Applications of Isotopes

Figure 6.4 Applications of Isotopes Challenges Associated with Isotopes

Figure 6.5 Challenges Associated with Isotopes

Figure 6.6 Recent Developments and Future Perspectives

Figure 7.1 Medical Isotope Manufacturers: Distribution by Year of Establishment

Figure 7.2 Medical Isotope Manufacturers: Distribution by Company Size

Figure 7.3 Medical Isotope Manufacturers: Distribution by Location of Headquarters

Figure 7.4 Medical Isotope Manufacturers: Distribution by Source of Isotope

Figure 7.5 Medical Isotope Manufacturers: Distribution by Type of Isotope

Figure 7.6 Medical Isotope Manufacturers: Distribution by Type of Production Method

Figure 7.7 Medical Isotope Manufacturers: Distribution by Application Area

Figure 7.8 Medical Isotope Manufacturers: Distribution by End-User

Figure 8.1 Company Competitiveness Analysis: Medical Isotope Manufacturers based in North America (Peer Group I)

Figure 8.2 Company Competitiveness Analysis: Medical Isotope Manufacturers based in Europe (Peer Group II)

Figure 8.3 Company Competitiveness Analysis: Medical Isotope Manufacturers based in Asia-Pacific and Rest of the World (Peer Group III)

Figure 8.4 Company Competitiveness Analysis: Benchmarking of Company Strength Score

Figure 8.5 Company Competitiveness Analysis: Benchmarking of Portfolio Strength Score

Figure 8.6 Company Competitiveness Analysis: Benchmarking of Portfolio Diversity Score

Figure 9.1 Cardinal Health: Manufacturing Portfolio

Figure 9.2 Curium Pharma: Manufacturing Portfolio

Figure 9.3 Eden Radioisotopes: Manufacturing Portfolio

Figure 9.4 NorthStar Medical Radioisotopes: Manufacturing Portfolio

Figure 9.5 Nusano: Manufacturing Portfolio

Figure 9.6 SpectronRx: Manufacturing Portfolio

Figure 10.1 ABX advanced biochemical compounds: Manufacturing Portfolio

Figure 10.2 CMR Isotopes: Manufacturing Portfolio

Figure 10.3 Eckert & Ziegler: Manufacturing Portfolio

Figure 10.4 ROTOP Pharmaka: Manufacturing Portfolio

Figure 12.1 Partnerships and Collaborations: Distribution by Year of Partnership, Since 2023

Figure 12.2 Partnerships and Collaborations: Distribution by Type of Partnership

Figure 12.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, Since 2023

Figure 12.4 Partnerships and Collaborations: Distribution by Type of Isotope Offered

Figure 12.5 Partnerships and Collaborations: Distribution by Application Area

Figure 12.6 Most Active Players: Distribution by Number of Partnerships

Figure 12.7 Partnerships and Collaborations: Local and International Deals

Figure 12.8 Partnerships and Collaborations: Intracontinental and Intercontinental Deals

Figure 13.1 Funding and Investments Analysis: Distribution of Instances by Year of Funding, Since 2023

Figure 13.2 Funding and Investments Analysis: Distribution of Instances by Type of Funding

Figure 13.3 Funding and Investments Analysis: Distribution of Instances by Year and Type of Funding, Since 2023

Figure 13.4 Funding and Investments Analysis: Distribution of Amount by Year of Funding, Since 2023 (USD Million)

Figure 13.5 Funding and Investments Analysis: Distribution of Amount by Type of Funding (USD Million)

Figure 13.6 Funding and Investments Analysis: Distribution of Amount by Year and Type of Funding, Since 2023 (USD Million)

Figure 13.7 Funding and Investments Analysis: Distribution by Geography

Figure 13.8 Most Active Players: Distribution by Number of Instances

Figure 13.9 Most Active Players: Distribution by Amount Raised (USD Million)

Figure 13.10 Most Active Investors: Distribution by Number of Instances

Figure 13.11 Funding and Investment Summary, Since 2023 (USD Million)

Figure 14.1 Medical Isotope Production: Market Drivers

Figure 14.2 Medical Isotope Production: Market Restraints

Figure 14.3 Medical Isotope Production: Market Opportunities

Figure 14.4 Medical Isotope Production: Market Challenges

Figure 15.1 Global Medical Isotope Production Market, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 15.2 Global Medical Isotope Production Market, Forecasted Estimates (Till 2040): Conservative Scenario (USD Billion)

Figure 15.3 Global Medical Isotope Production Market, Forecasted Estimates (Till 2040): Optimistic Scenario (USD Billion)

Figure 16.1 Medical Isotope Production Market: Distribution by Scale of Operation

Figure 16.2 Medical Isotope Production Market for Commercial Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 16.3 Medical Isotope Production Market for Preclinical / Clinical Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 17.1 Medical Isotope Production Market: Distribution by Type of Isotope

Figure 17.2 Medical Isotope Production Market for Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 17.3 Medical Isotope Production Market for Stable Isotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 18.1 Medical Isotope Production Market: Distribution by Type of Radioisotope

Figure 18.2 Medical Isotope Production Market for Technetium-99m, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 18.3 Medical Isotope Production Market for Lutetium-177, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 18.4 Medical Isotope Production Market for Fluorine-18, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 18.5 Medical Isotope Production Market for Other Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 19.1 Medical Isotope Production Market: Distribution by Type of Production Method

Figure 19.2 Medical Isotope Production Market for Nuclear Reactors, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 19.3 Medical Isotope Production Market for Accelerators, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 19.4 Medical Isotope Production Market for Other Methods, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 20.1 Medical Isotope Production Market: Distribution by Application Area

Figure 20.2 Medical Isotope Production Market for Diagnosis, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 20.3 Medical Isotope Production Market for Nuclear Therapy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 20.4 Medical Isotope Production Market for Other Applications, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 21.1 Medical Isotope Production Market: Distribution by Type of Diagnostic Radioisotope

Figure 21.2 Medical Isotope Production Market for SPECT Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 21.3 Medical Isotope Production Market for PET Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 22.1 Medical Isotope Production Market: Distribution by Type of Therapeutic Radioisotope

Figure 22.2 Medical Isotope Production Market for Gamma Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 22.3 Medical Isotope Production Market for Beta Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 22.4 Medical Isotope Production Market for Other Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 23.1 Medical Isotope Production Market: Distribution by Therapeutic Area

Figure 23.2 Medical Isotope Production Market for Oncological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 23.3 Medical Isotope Production Market for Cardiovascular Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 23.4 Medical Isotope Production Market for Neurological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 23.5 Medical Isotope Production Market for Other Areas, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 24.1 Medical Isotope Production Market: Distribution by End-Users

Figure 24.2 Medical Isotope Production Market for Hospitals, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 24.3 Medical Isotope Production Market for Diagnostic Centers, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 24.4 Medical Isotope Production Market for Research Institutes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.1 Medical Isotope Production Market: Distribution by Geographical Regions

Figure 25.2 Medical Isotope Production Market in North America, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.3 Medical Isotope Production Market in the US, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.4 Medical Isotope Production Market in Canada, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.5 Medical Isotope Production Market in Europe, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.6 Medical Isotope Production Market in Germany, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.7 Medical Isotope Production Market in UK, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.8 Medical Isotope Production Market in France, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.9 Medical Isotope Production Market in Italy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.10 Medical Isotope Production Market in Spain, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.11 Medical Isotope Production Market in Rest of Europe, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.12 Medical Isotope Production Market in Asia-Pacific, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.13 Medical Isotope Production Market in China, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.14 Medical Isotope Production Market in Japan, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.15 Medical Isotope Production Market in Australia, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.16 Medical Isotope Production Market in South Korea, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.17 Medical Isotope Production Market in India, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.18 Medical Isotope Production Market in Rest of Asia-Pacific, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.19 Medical Isotope Production Market in the Middle East and Africa, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.20 Medical Isotope Production Market in Saudi Arabia, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.21 Medical Isotope Production Market in UAE, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.22 Medical Isotope Production Market in Egypt, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.23 Medical Isotope Production Market in Latin America, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.24 Medical Isotope Production Market in Brazil, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.25 Medical Isotope Production Market in Mexico, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.26 Medical Isotope Production Market in Argentina, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Figure 25.27 Market Movement Analysis: Geographical Regions

Figure 25.28 Penetration Growth (P-G) Matrix: Geographical Regions

Figure 31.1 Vendor Selection Framework: Benchmarking of Parameters

Figure 31.2 Vendor Selection Framework: Value Addition vs Evaluation Complexity Matrix

+ List of Tables

Table 7.1 List of Medical Isotope Manufacturers: Information on Year of Establishment, Employee Count, Company Size, and Headquarters

Table 7.2 Medical Isotope Manufacturers: Information on Source of Isotope

Table 7.3 Medical Isotope Manufacturers: Information on Type of Isotope, Type of Production Method, Application Area and End-user

Table 12.1 Medical Isotope Production: List of Partnerships and Collaborations, Since 2020

Table 12.2 Medical Isotope Production: Information on Location of Headquarters (Country / Region) and Type of Agreement (Country / Region)

Table 13.1 Medical Isotope Production: List of Funding and Investments, Since 2020 Table 27.1 Medical Isotope Production Market in North America: Distribution by Scale of Operation, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 27.2 Medical Isotope Production Market in North America: Distribution by Type of Isotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 27.3 Medical Isotope Production Market in North America: Distribution by Type of Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 27.4 Medical Isotope Production Market in North America: Distribution by Type of Production Method, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 27.5 Medical Isotope Production Market in North America: Distribution by Application Area, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 27.6 Medical Isotope Production Market in North America: Distribution by Type of Diagnostic Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 27.7 Medical Isotope Production Market in North America: Distribution by Type of Therapeutic Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 27.8 Medical Isotope Production Market in North America: Distribution by Therapeutic Area, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 27.9 Medical Isotope Production Market in North America: Distribution by End-Users, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 28.1 Medical Isotope Production Market in Europe: Distribution by Scale of Operation, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 28.2 Medical Isotope Production Market in Europe: Distribution by Type of Isotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 28.3 Medical Isotope Production Market in Europe: Distribution by Type of Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 28.4 Medical Isotope Production Market in Europe: Distribution by Type of Production Method, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 28.5 Medical Isotope Production Market in Europe: Distribution by Application Area, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 28.6 Medical Isotope Production Market in Europe: Distribution by Type of Diagnostic Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 28.7 Medical Isotope Production Market in Europe: Distribution by Type of Therapeutic Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 28.8 Medical Isotope Production Market in Europe: Distribution by Therapeutic Area, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 28.9 Medical Isotope Production Market in Europe: Distribution by End-Users, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 29.1 Medical Isotope Production Market in Asia-Pacific: Distribution by Scale of Operation, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 29.2 Medical Isotope Production Market in Asia-Pacific: Distribution by Type of Isotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 29.3 Medical Isotope Production Market in Asia-Pacific: Distribution by Type of Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 29.4 Medical Isotope Production Market in Asia-Pacific: Distribution by Type of Production Method, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 29.5 Medical Isotope Production Market in Asia-Pacific: Distribution by Application Area, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 29.6 Medical Isotope Production Market in Asia-Pacific: Distribution by Type of Diagnostic Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 29.7 Medical Isotope Production Market in Asia-Pacific: Distribution by Type of Therapeutic Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 29.8 Medical Isotope Production Market in Asia-Pacific: Distribution by Therapeutic Area, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 29.9 Medical Isotope Production Market in Asia-Pacific: Distribution by End-Users, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 30.1 Medical Isotope Production Market in the Middle East and Africa: Distribution by Scale of Operation, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 30.2 Medical Isotope Production Market in the Middle East and Africa: Distribution by Type of Isotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 30.3 Medical Isotope Production Market in the Middle East and Africa: Distribution by Type of Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 30.4 Medical Isotope Production Market in the Middle East and Africa: Distribution by Type of Production Method, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 30.5 Medical Isotope Production Market in the Middle East and Africa: Distribution by Application Area, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 30.6 Medical Isotope Production Market in the Middle East and Africa: Distribution by Type of Diagnostic Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 30.7 Medical Isotope Production Market in the Middle East and Africa: Distribution by Type of Therapeutic Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 30.8 Medical Isotope Production Market in the Middle East and Africa: Distribution by Therapeutic Area, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 30.9 Medical Isotope Production Market in the Middle East and Africa: Distribution by End-Users, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 31.1 Medical Isotope Production Market in Latin America: Distribution by Scale of Operation, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 31.2 Medical Isotope Production Market in Latin America: Distribution by Type of Isotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 31.3 Medical Isotope Production Market in Latin America: Distribution by Type of Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 31.4 Medical Isotope Production Market in Latin America: Distribution by Type of Production Method, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 31.5 Medical Isotope Production Market in Latin America: Distribution by Application Area, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 31.6 Medical Isotope Production Market in Latin America: Distribution by Type of Diagnostic Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 31.7 Medical Isotope Production Market in Latin America: Distribution by Type of Therapeutic Radioisotope, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 31.8 Medical Isotope Production Market in Latin America: Distribution by Therapeutic Area, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 31.9 Medical Isotope Production Market in Latin America: Distribution by End-Users, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

**Detailed information on Tables 27.1-31.9 is available in the Excel Data Packs shared along with the report**

Table 34.1 Medical Isotope Manufacturers: Distribution by Year of Establishment

Table 34.2 Medical Isotope Manufacturers: Distribution by Company Size

Table 34.3 Medical Isotope Manufacturers: Distribution by Location of Headquarters (Region)

Table 34.4 Medical Isotope Manufacturers: Distribution by Source of Isotope

Table 34.5 Medical Isotope Manufacturers: Distribution by Type of Isotope

Table 34.6 Medical Isotope Manufacturers: Distribution by Type of Production Method

Table 34.7 Medical Isotope Manufacturers: Distribution by Application Area

Table 34.8 Medical Isotope Manufacturers: Distribution by End-users

Table 34.9 Partnerships and Collaborations: Distribution by Year of Partnership, Since 2023

Table 34.10 Partnerships and Collaborations: Distribution by Type of Partnership

Table 34.11 Partnerships and Collaborations: Distribution by Year and Type of Partnership, Since 2023

Table 34.12 Partnerships and Collaborations: Distribution by Isotope Offered

Table 34.13 Partnerships and Collaborations: Distribution by Application Area

Table 34.14 Partnerships and Collaborations: Most Active Players

Table 34.15 Partnerships and Collaborations: Local and International Deals

Table 34.16 Partnerships and Collaborations: Intracontinental and Intercontinental Deals

Table 34.17 Funding and Investments Analysis: Distribution of Instances by Year of Funding, Since 2023

Table 34.18 Funding and Investments Analysis: Distribution of Instances by Type of Funding

Table 34.19 Funding and Investments Analysis: Distribution of Instances by Year and Type of Funding, Since 2023

Table 34.20 Funding and Investments Analysis: Distribution of Amount by Year of Funding (USD Million)

Table 34.21 Funding and Investments Analysis: Distribution of Amount Raised by Year and Type of Funding (USD Million)

Table 34.22 Funding and Investments Analysis: Distribution by Geography

Table 34.23 Most Active Players: Distribution by Number of Funding Instances

Table 34.24 Most Active Players: Distribution by Amount Raised (USD Million)

Table 34.25 Most Active Investors: Distribution by Number of Funding Instances

Table 34.26 Funding and Investment Summary, Since 2023 (USD Million)

Table 34.27 Global Medical Isotope Production Market, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040) (USD Billion)

Table 34.28 Global Medical Isotope Production Market, Forecasted Estimates (Till 2040): Conservative Scenario (USD Billion)

Table 34.29 Global Medical Isotope Production Market, Forecasted Estimates (Till 2040): Optimistic Scenario (USD Billion)

Table 34.30 Medical Isotope Production Market: Distribution by Scale of Operation

Table 34.31 Medical Isotope Production Market for Commercial Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.32 Medical Isotope Production Market for Preclinical / Clinical Scale, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.33 Medical Isotope Production Market: Distribution by Type of Isotope

Table 34.34 Medical Isotope Production Market for Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios(USD Billion)

Table 34.35 Medical Isotope Production Market for Stable Isotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.36 Medical Isotope Production Market: Distribution by Type of Radioisotope

Table 34.37 Medical Isotope Production Market for Technetium-99m, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.38 Medical Isotope Production Market for Lutetium-177, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.39 Medical Isotope Production Market for Fluorine-18, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.40 Medical Isotope Production Market for Other Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.41 Medical Isotope Production Market: Distribution by Type of Production Method

Table 34.42 Medical Isotope Production Market for Nuclear Reactors, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.43 Medical Isotope Production Market for Accelerators, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.44 Medical Isotope Production Market for Other Methods, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.45 Medical Isotope Production Market: Distribution by Application Area

Table 34.46 Medical Isotope Production Market for Diagnosis, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.47 Medical Isotope Production Market for Nuclear Therapy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.48 Medical Isotope Production Market for Other Applications, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.49 Medical Isotope Production Market: Distribution by Type of Diagnostic Radioisotope

Table 34.50 Medical Isotope Production Market for SPECT Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.51 Medical Isotope Production Market for PET Radioisotopes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.52 Medical Isotope Production Market: Distribution by Type of Therapeutic Radioisotope

Table 34.53 Medical Isotope Production Market for Gamma Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.54 Medical Isotope Production Market for Beta Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.55 Medical Isotope Production Market for Other Emitters, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.56 Medical Isotope Production Market: Distribution by Therapeutic Area

Table 34.57 Medical Isotope Production Market for Oncological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.58 Medical Isotope Production Market for Cardiovascular Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.59 Medical Isotope Production Market for Neurological Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.60 Medical Isotope Production Market for Other Areas, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.61 Medical Isotope Production Market: Distribution by End-Users

Table 34.62 Medical Isotope Production Market for Hospitals, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.63 Medical Isotope Production Market for Diagnostic Centers, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.64 Medical Isotope Production Market for Research Institutes, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.65 Medical Isotope Production Market: Distribution by Geographical Regions

Table 34.66 Medical Isotope Production Market in North America, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.67 Medical Isotope Production Market in the US, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.68 Medical Isotope Production Market in Canada, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.69 Medical Isotope Production Market in Europe, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.70 Medical Isotope Production Market in Germany, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.71 Medical Isotope Production Market in UK, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.72 Medical Isotope Production Market in France, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.73 Medical Isotope Production Market in Italy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.74 Medical Isotope Production Market in Spain, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.75 Medical Isotope Production Market in Rest of Europe, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.76 Medical Isotope Production Market in Asia-Pacific, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.77 Medical Isotope Production Market in China, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.78 Medical Isotope Production Market in Japan, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.79 Medical Isotope Production Market in Australia, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.80 Medical Isotope Production Market in South Korea, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.81 Medical Isotope Production Market in India, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.82 Medical Isotope Production Market in Rest of Asia-Pacific, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.83 Medical Isotope Production Market in the Middle East and Africa, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.84 Medical Isotope Production Market in Saudi Arabia, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.85 Medical Isotope Production Market in UAE, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.86 Medical Isotope Production Market in Egypt, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.87 Medical Isotope Production Market in Latin America, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.88 Medical Isotope Production Market in Brazil, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.89 Medical Isotope Production Market in Mexico, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Table 34.90 Medical Isotope Production Market in Argentina, Historical Trends (Since 2023) and Forecasted Estimates (Till 2040): Conservative, Base and Optimistic Scenarios (USD Billion)

Medical Isotope Production Market